tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

Vicarious Surgical Updates Investor Presentation on Robotic System

Story Highlights
Vicarious Surgical Updates Investor Presentation on Robotic System

Elevate Your Investing Strategy:

  • Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.

Vicarious Surgical ( (RBOT) ) has issued an announcement.

On September 23, 2025, Vicarious Surgical Inc. updated its investor presentation, highlighting its progress towards commercializing its single-port surgical robot, the Vicarious Surgical System. The company emphasizes its potential to redefine robotic surgery by offering open-surgery access through a small incision, which could expand the market for robotic procedures beyond current limitations. This advancement is expected to improve patient outcomes and operational efficiency, particularly in procedures like ventral hernia repair, where traditional systems fall short.

The most recent analyst rating on (RBOT) stock is a Hold with a $7.00 price target. To see the full list of analyst forecasts on Vicarious Surgical stock, see the RBOT Stock Forecast page.

Spark’s Take on RBOT Stock

According to Spark, TipRanks’ AI Analyst, RBOT is a Underperform.

Vicarious Surgical’s stock score reflects significant financial challenges as a pre-revenue company with high cash burn, offset by a moderately stable balance sheet. Technical analysis indicates bearish sentiment, compounded by valuation challenges due to negative earnings. While the earnings call showed strategic advancements, supply chain delays and NYSE compliance issues pose risks. Successful clinical trials and improved cash management will be critical for future performance.

To see Spark’s full report on RBOT stock, click here.

More about Vicarious Surgical

Vicarious Surgical Inc. operates in the medical technology industry, focusing on developing advanced robotic systems for minimally invasive surgery. Their primary product, the Vicarious Surgical System, aims to provide open-like access through a single incision, targeting a large untapped market of over 5.6 million abdominal procedures annually in the U.S. The company holds a significant intellectual property portfolio with 160 patents granted and pending, and is advancing towards commercialization.

Average Trading Volume: 33,674

Technical Sentiment Signal: Sell

Current Market Cap: $35.48M

Learn more about RBOT stock on TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1